THEMISMED vs VIYASH: Stock Comparison

Themis Medicare Limited vs Viyash Scientific Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Themis Medicare Limited shows a higher dividend yield and faster revenue growth, while Viyash Scientific Ltd shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Themis Medicare Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, THEMISMED is more favourable on 3 of 13 scored metrics and VIYASH on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,038 Cr vs ₹972 Cr
P/E Ratio
VIYASH has a lower P/E
62.48x vs 883.33x
P/B Ratio
THEMISMED has a lower P/B
2.45x vs 3.81x
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹0.12
Dividend Yield
THEMISMED has a higher dividend yield
0.43% vs 0%
Revenue Growth (TTM YoY)
THEMISMED has faster revenue growth
6.7% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 6.74%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
455% vs 192%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricTHEMISMEDVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricTHEMISMEDVIYASH
Live Price₹105.78₹253.45
Day Change-1.99%-2.41%
Volume34,2719.28 L
52-Week High₹148₹298
52-Week Low₹64.95₹178.13
Distance from 52W High-28.53%-14.95%

Valuation

MetricTHEMISMEDVIYASH
Market Cap₹972 Cr₹11,038 Cr
P/E Ratio883.33x62.48x
P/B Ratio2.45x3.81x
EPS₹0.12₹4.06
Book Value₹43.06₹66.6
Dividend Yield0.43%0%

Growth

MetricTHEMISMEDVIYASH
Revenue Growth (TTM YoY)6.7%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth6.74%129%
Qtr Profit Growth192%455%

Profitability & Leverage

MetricTHEMISMEDVIYASH
ROE0.29%11%
ROCE2.74%19%
Net Margin0.33%6.57%
Operating Margin-2.9%19.1%
Debt to Equity25.11x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricTHEMISMEDVIYASH
Promoter Holding57.5%0%
FII Holding0.01% 0.1 pp4.5% 1.56 pp
DII Holding0.01%3.75% 4.24 pp
Public Holding32.87% 0.09 pp30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Themis Medicare Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.